Journal article
Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy
Abstract
BACKGROUND: Immune checkpoint inhibitors (ICI) have demonstrated impressive activity in metastatic clear-cell renal cell carcinoma (ccRCC) and have become standard treatment options for patients with advanced disease. Data supporting the effectiveness of ICI-based therapy in advanced non-clear cell RCC (nccRCC) is more limited.
METHODS: We performed a retrospective analysis using the International Metastatic RCC Database Consortium (IMDC) to …
Authors
Graham J; Wells JC; Dudani S; Gan CL; Donskov F; Lee J-L; Kollmannsberger CK; Meza L; Beuselinck B; Hansen A
Journal
European Journal of Cancer, Vol. 171, , pp. 124–132
Publisher
Elsevier
Publication Date
August 2022
DOI
10.1016/j.ejca.2022.05.002
ISSN
0959-8049